ð¤Óí▒ß>■
O■ ■ N
T8═╔ß░┴Ô\p
Hilla my love
B░a└=£»╝=Çp278X@ì"
À┌1╚ É▒,Arial1╚ É▒,Arial1╚ É▒,Arial1╚ É▒,Arial1. É,Times New
Roman1╚
É▒,Arial1╚$É▒,Arial1á É▒,Arial1╚ É▒,Arial1.
É,Times New Roman1. ╝,Times New Roman1.?É,Times New
Roman1.@ ╝,Times New Roman1 É,Arial1▄É▒~Arial1▄
É▒~Arial1▄4╝▒~Arial1▄É▒~Arial1▄
É▒~Arial1▄É▒~Arial1.h8╝▒~Times New
Roman1,8╝▒~Arial18╝▒~Arial1▄8╝▒~Arial1▄<É▒~Arial1▄╝▒~Arial1▄?
╝▒~Arial1▄>É▒~Arial1▄É▒~Arial1▄ ╝▒~Arial1▄4É▒~Arial1.É~Times New
Roman1.
É~Times New Roman1. É~Times New Roman1.É~Times New Roman1.
É~Times New Roman1.?É~Times New Roman-3"¬ "\ #,##0;"¬ "\ \-#,##0-="¬
"\ #,##0;[Red]"¬ "\ \-#,##0-?"¬ "\ #,##0.00;"¬ "\ \-#,##0.00-I""¬ "\
#,##0.00;[Red]"¬ "\ \-#,##0.00-u*8_ "¬ "\ * #,##0_ ;_ "¬ "\ * \-
#,##0_ ;_ "¬ "\ * "-"_ ;_ @_ -.))_ * #,##0_ ;_ * \-#,##0_ ;_ *
"-"_ ;_ @_ -à,@_ "¬ "\ * #,##0.00_ ;_ "¬ "\ * \-#,##0.00_ ;_ "¬ "\ *
"-"??_ ;_ @_ -6+1_ * #,##0.00_ ;_ * \-#,##0.00_ ;_ * "-"??_ ;_ @_
-ñ"Yes";"Yes";"No"-Ñ"True";"True";"False"-ª"On";"On";"Off"-]º,[$¼ -
2]\ #,##0.00_);[Red]\([$¼ -2]\ #,##0.00\)Ó§ └ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└
Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└
Ó§ ¶└ Ó └ Ó§ ┤ƒ Ó§ ┤¡ Ó§ ┤¬ Ó§ ┤« Ó§ ┤ø Ó§ ┤» Ó§ ┤¼ Ó§ ┤Ø
Ó§ ┤ï Ó§ ┤« Ó§ ┤¼ Ó§ ┤│ Ó§ ┤× Ó§ ┤Ø Ó§ ┤ï Ó§ ┤ñ Ó§ ┤▒ Ó§ ┤┤
Ó+§ °└ Ó,§ °└ Ó § °└ Ó§ ┤¥ Ó§ ┤è Ó§ ┤╣ Ó§ ┤ñ Ó§ ┤▒ Ó§ ┤Á
Ó¶ ¶└ Ó¶ ¶└ Ó § £
Ü Ó§ öù
ù
û Ó§ ┤¬ Ó§ ¶└ Ó§ ¶└ Ó§ ¶└ Ó§ ÈP└ Ó§ ÈP
└ Ó§ È └ Ó§ ¶└ Ó*§ °└ Ó§ ┤½ Ó§ Èa>└ Ó§ ö┐┐û Ó)§ °└ Ó§ öù
ù
» Ó§ ┤¡ Ó-§ öff┐┐À Ó§ È`└ Ó▒░@ @ └ Ó8@ @ └ Ó8@ @ └ Ó@8@ @ └ Ó
▒©@ @ └ Ó
▒©@ @ └ Ó@x@ @ └ Ó
8@ @ └ Ó
h@ @
Ó
h@ @
Ó
└ Ó 8@└ Ó 8 └ Ó 8@ @ └ Ó8@ @└ Ó
▒©@ @└ Ó!▒©@ @ └ Ó"@└ Ó"8@ @ └ Ó!▒Çÿ└ Ó"8@ @ └ Ó"@8@ @ └ ÓÇ8@ @ └ Ó @8@ @
└ Ó8@ @└ Ó"└ Ó"8@ @ └ Ó"@8@ @ └ Ó"(8@ @ └ ÓÇ8@ @ └ Ó"Ç8@ @└ Ó"Ç8@ @ └
Ó"@8@ @ └ Ó#x@ @ └ Ó!▒©@ @└ Ó"└ Ó!▒Ç©@ @ └ Ó!▒©@ @ └ Ó$8@ @ └ Ó!▒Ç©@ @ └
Ó!▒ÿ└ Ó!▒©@ @ └ Ó"8@ @ └ Ó"x@ @ └ Ó%x@ @ └ Ó
▒©@ @ └ Ó"x@ @ └ Ó"8@ @ └ Ó8@ @ └ Ó#x@ @ └ ÓÇ8@ @ └ Ó└ Ó"@8@ @ └ ||
u═▀[ñ}-}
00_)
}-}
00_)
}-}
00_)
}-}
00_)
}A}
00_)
ef[$¼ -}A}
00_)
ef [$¼ -}A}
00_)
╠L[$¼ -}A}
00_)
╠L[$¼ -}-}
00_)
}A}
00_)
╠L[$¼ -}A}
00_)
╠L[$¼ -}A}
00_)
╠L [$¼ -}A}
00_)
23[$¼ -}A}
00_)
23[$¼ -}-}-
00_)
}-}
00_)
}A}
00_)
23[$¼ -}-}!
00_)
}A}%
00_)
[$¼ -}A}&
00_)
[$¼ -}A}'
00_)
[$¼ -}A}(
00_)
[$¼ -}A})
00_)
[$¼ -}A}*
00_)
[$¼ -}x}- ╠ 00_)▓▓▓ [$▓▓▓ #,## ▓▓▓ "¬ "\
▓▓▓ ??_ }æ}.
·} 00_)
‗‗‗ [$ ## "\
_ ;_
}A}/
a 00_)
ã´╬ [$}-}0
00_)
}-}1
00_)
}-}2
00_)
}A}3
00_)
[$}A}4
00_)
?[$}A}5
00_)
23[$}-}6
00_)
}A}8
£e 00_)
Ù£ [$}U}9
00_)
[$## }æ}:
??? 00_)
‗‗‗ [$??? ## ??? "\
??? _ ;_
??? }æ}<
??v 00_)
̙ [$ ## "\
_ ;_
}A}=
£ 00_)
Ã╬ [$}æ}>
00_)
ÑÑÑ [$??? ## ??? "\
??? _ ;_
??? }A}?
·} 00_)
Ç [$}(}K
00_)}(}L
00_)}(}M
00_)}}P
}}Q
}}R
}}S
}}T
}}U
}(}W
00_)}}Y
}}Z
}}[
}}\
}}^
}}_
}}`
}}a
}}b
}}c
}}d
}}e
}}f
}}g
}}h
}}i
}}j
}}k
}}l
}}n
}}o
}}q
}}t
ô
20% - ÈËÊÚÈ1Æ?Æ-
20% - ÈËÊÚÈ1
%ô
20% - ÈËÊÚÈ2Æ?Æ"
20% - ÈËÊÚÈ2
%ô
20% - ÈËÊÚÈ3Æ?Æ&
20% - ÈËÊÚÈ3
%ô
20% - ÈËÊÚÈ4Æ?Æ*
20% - ÈËÊÚÈ4
%ô
20% - ÈËÊÚÈ5ÆKÆ.
20% - ÈËÊÚÈ5
ef┌¯¾
%ô
20% - ÈËÊÚÈ6ÆKÆ2
20% - ÈËÊÚÈ6
ef²Ú┘
%ô
40% - ÈËÊÚÈ1ÆKÆ
40% - ÈËÊÚÈ1
╠L©╠õ
%ô
40% - ÈËÊÚÈ2ÆKÆ#
40% - ÈËÊÚÈ2
╠Lµ©À
%ô
40% - ÈËÊÚÈ3Æ?Æ'
40% - ÈËÊÚÈ3
%ô
40% - ÈËÊÚÈ4ÆKÆ+
40% - ÈËÊÚÈ4
╠L╠└┌
%ô
40% - ÈËÊÚÈ5ÆKÆ/
40% - ÈËÊÚÈ5
╠LÀÌÞ
%ô
40% - ÈËÊÚÈ6ÆKÆ3
40% - ÈËÊÚÈ6
╠L³ı┤
%ô
60% - ÈËÊÚÈ1ÆKÆ
60% - ÈËÊÚÈ1
23ò│Î
%ô
60% - ÈËÊÚÈ2ÆKÆ$
60% - ÈËÊÚÈ2
23┌ûö
%ô-
60% - ÈËÊÚÈ3Æ?Æ(
60% - ÈËÊÚÈ3
%ô
60% - ÈËÊÚÈ4Æ?Æ,
60% - ÈËÊÚÈ4
%ô
60% - ÈËÊÚÈ5ÆKÆ0
60% - ÈËÊÚÈ5
23Æ═▄
%ô!
60% - ÈËÊÚÈ6Æ?Æ4
60% - ÈËÊÚÈ6
%ô"Ç Æ Æ Commaô#Ç Æ&Æ CurrencyôÇ Æ"Æ Normalô$Ç Æ$Æ Percentô
%ÈËÊÚÈ1Æ?Æ ÈËÊÚÈ1
Oü¢
%ô&ÈËÊÚÈ2Æ?Æ! ÈËÊÚÈ2
└PM
%ô'ÈËÊÚÈ3Æ?Æ% ÈËÊÚÈ3
ø╗Y
%ô(ÈËÊÚÈ4Æ?Æ) ÈËÊÚÈ4
Çdó
%ô)ÈËÊÚÈ5Æ?Æ- ÈËÊÚÈ5
K¼ã
%ô*ÈËÊÚÈ6Æ?Æ1 ÈËÊÚÈ6
¸ûF
%ô+Ç Æ*Æ
È┘õÞ-þ┘ÚıÞô,Ç Æ8Æ È┘õÞ-þ┘ÚıÞ ÚÈıõÔ▄ô
-ÈÔÞÈÆbÆ
ÈÔÞÈ
╠
▓▓▓
▓▓▓
▓▓▓
▓▓▓ ô.Î┘ÚıÐÆuÆ Î┘ÚıÐ
‗‗‗
·} %
ô
/ÏıÐÆ9Æ ÏıÐ
ã´╬
a %ô0
ÏþßÏ ðÍÈÞÈÆ;Æ
ÏþßÏ ðÍÈÞÈ
%ô1
ÏþßÏ ÈßÐÞ┘Æ;Æ5
ÏþßÏ ÈßÐÞ┘
%ô2█ıÛÞÛÆ1Æ █ıÛÞÛ
I} %ô3█ıÛÞÛ 1ÆCÆ █ıÛÞÛ 1
I} %
Oü¢ ô4█ıÛÞÛ 2ÆCÆ █ıÛÞÛ 2
I} %
?º┐Ì ô5█ıÛÞÛ 3ÆCÆ █ıÛÞÛ 3
I} %
23ò│Î ô6█ıÛÞÛ 4Æ5Æ █ıÛÞÛ 4
I} %ô7Ç Æ&Æ ÌÏÐÔ [0]ô8Ó┘ÏÞð▄┘ÆAÆ Ó┘ÏÞð▄┘
Ù£
£e %ô
9ßÈ"█ÆKÆ ßÈ"█
%
Oü¢
Oü¢ ô
:õ▄ÏÆqÆ õ▄Ï
‗‗‗
??? %
???
???
???
??? ô;Ç Æ&Æ õß┘þ [0]ô
<þ▄ÏÆqÆ þ▄Ï
̙
??v %
ô =ÞÔÆ7Æ ÞÔ
Ã╬
£ %ô>Ûð ÌßıÌ▀Æ{Æ Ûð ÌßıÌ▀
ÑÑÑ
%
???
???
???
??? ô?Ûð ÌþıÚÞÆEÆ Ûð ÌþıÚÞ
·} %
Ç ÄXÄÉTableStyleMedium9PivotStyleLight16`àE\Ê┘▄┘ı▀1à
wÊ┘▄┘ı▀2àøxÊ┘▄┘ı▀3ÜÜúúî╠╠┴┴"¥³ │®Project
Researcher
DepartmentEmail
052-6666291
Neurosurgery
Gynecology4Innovative drug treatment in the Fragile X
syndrome.#[email protected]
[email protected]
Psychiatry.The Zabluzowicz Center For Autoimmune Diseases
052-4543949
[email protected]
[email protected]
052-6667352 á
Dr. Adi Leiba
057-8143197á(Institute of Nephrology and Hypertension
%[email protected] Lab.
052-2528500Dr. Limor Ziv-Strasser Dr. Liat Gindes
Dr. Yishay SalemDr.Shahar Shefer [email protected]
[email protected]%Dr. Smadar Gertel
Prof. Howard [email protected]
[email protected]#Dr. Ilan Ben-Zvi
Dr. Hava Ben DavidÇThe role of Toll like receptors (TLRs) 2 and 4 as
activators of the inflammasome in Familial Mediterranean fever (FMF)
patients.Dr. Sagi Har Nof
054-4896620á [email protected]á£1. Normal variability
of aortic arch branches in the fetus as demonstrated by ultrasound.
2. Post Mortem fetal MRI of cardiac and vasculature
[email protected]
Dr. Raz Gross
054-4929950á
052-6668520 [email protected]ü1. Prenatal, perinatal
and early life risk facctors for autism
2. The interrelationship between psychiatric and medical condition
[email protected]. Joab Chapman
052-6666170á NeurologyYDevelopment of specific immune therapy for
rheumatoid arthritis using synthetic peptides.¬Theáeffect áof
Chemoteraphy for remission induction in Multiple myeloma patients on
arterial stiffness, ámarkers of inflammation and oxidative stress and
disease outcome.5Environment and Epigenetics in Zebrafish
Development.
1. Brain Cavernoma pilot survey to national based survey.
2. The involvement of Thrombin, Thrombin receptor PAR-1 in brain edema
secondary to Intra Cerebral Hemorrhage (ICH), And the efficacy of PRA-1
antagonist for the reduction of brain edema and improve survival.
3. The efficacy of NSAIDs t oreduce brain edema in a rat brain tumor
model.
4. The application of CT for determining BBB abnormalities
in cerebrovascular disease.
The application of CT for determining BBB abnormalities
in cerebrovascular disease.
6Rheumatology Unit &
Department of Internal Medicine FHCharacterizing novel autoantigens in
autoimmune nervous system diseases.Prof. Anat Achiron
Roy AloniDr. Meir Plotnik
052-6668506%[email protected]▀The use of advanced
virtual reality systems for studying sensory motor integration and its
role in improving motor learning capabilities for rehabilitation purposes
of gait and posture in patients with chronic diseases.
Rehabilitation
[email protected] of the prevalence of
IgG4-related disease in patients
undergoing orbital biopsy in the Tel Hashomer Department of
Ophthalmology; evaluation of the impact of IgG4 disease on clinical
course; investigation of an association of IgG4 disease with orbital
lymphoma.Prof. Guy Ben Simon
Ophthalmology*Based on our knowledge of brain plasticity, the purpose
of the research is to stimulate alternative neural pathways by cognitive
training based on computer programs and by that to create changes i
neuronal circuits that result improvement in cognitive abilities in
patients with multiple sclerosisuThe association between
neuroimumological factors and psychotic
symptoms and cognitive deficits in DiGeorge Syndrome:Autologous Fat
Grafting for Post Trauma/Malignancy Defects?Perinatal Complications After
Preimplanation Geneteic DiagnosisÁA registry of MDS patents treated in
the Chaim Sheba Medical center.
Association of baseline Body Mass Index (BMI) with Overall Survival among
Patients with Acute Myeloid LeukemiavThe relationship between bilateral
coordination of gait asymmetry in amputees. Identifying fall risk factors
amputees._Evaluation of pancreatic duct varient in patients with
Pancreatitis
and Biliary stone desease.nFetal brain evaluation by MRI in pregnancies
complicated by placental Intra-Uterine Growth Restriction
(IUGR).TPeripheral blood biomarkers for the diagnostics of acute multiple
sclerosis relapseMultiple Sclerosis
[email protected]. Doron GothelfPediatric
Psychiatry
[email protected]. Orit HamielPediatric
Endocrinology¼Obese children with characteristics of the metabolic
syndrome compared with obese children metabolic normal prevalence and
characteristics Retrospective chart sdudy (OMN)
[email protected]Dr. Itai Gat
Fertilization
[email protected]. Drorit Merkel
[email protected]á
052-6666510áOrthopedic RehabilitationDr. Itzhak Ziv-Ner
052-6666651"
[email protected]Dr. Michal
[email protected][email protected]"
[email protected][email protected]@sheba.health.gov.il
054-6744141
054-4775804
052-6668452
052-6668780
054-4718040FPelvic floor ultrasound, Ultrasound in the diagnosis of
endometriosisEvaluating hepatic injury before and after bariatric
surgery.
Incidence of hepatitis E virus in the general population and among
immune-suppressed patients.
Evaluating the development of viral resistance to the new protease
inhibitors in patients with chronic hepatitis C infection.ÅDevelopment of
treatments for autoimmune diseases based on natural compounds.
Tolerogenic dendritic cells for treatment of autoimmune diseases.┼Outcome
of 3000 patients who have been treated with
radiosurgery in the last 20 years.
Extended FU for any pathology (base of skull meningiomas
AVMs, neurinomas, pituitary tumors, metastases,
etc)
[email protected][email protected] [email protected]@yahoo.com
[email protected] [email protected][email protected]@sheba.health.gov.il-Iris.Morag@s
heba.health.gov.il
[email protected]054-6616513
054-4577233
052-6666330
052-6669252
052-6666681
052-6666175
050-7332557
052-6479996
052-6667138PHPV infection association with Recurrent Respiratory.
Papillomatosis in Israel.E
FnThe role of BMPs in arterial stiffness, renal osteodystrophy and
anemia in maintenance hemodialysis patients.Vesicular monoamine
transferase levels in eating disorder and
control participants.
Assessment of body composition i with bio-impedance in eating
disorders and control patients.
Assessment of attention and concentration functioning in eating disorder
and control participants.XLINGUAL NERVE STIMULATION DURING HEAD AND NECK
RADIATION TO IMPROVE XEROSTOMIA OUTCOMES.¤The involvement of Thrombin,
Thrombin receptor PAR-1 in brain edema secondary to Intra Cerebral
Hemorrhage (ICH). And the efficacy of PRA-1 antagonist for the reduction
of brainedema and improve survival. [Cardiac CT angiography (CCTA)-a new
non invasive modality for
coronary artery evaluation. àCharacterization of the temporal profile of
thrombin activity and its associated rec<eptors following ischemic stroke
in a mouse modelGOligodendrocytes derived from mouse brain as a model for
remyelination.BLong term outcomes of late preterm infants born at Sheba
Medical Center during Jan-Aug 2008.
This study will be conducted using questionnaires assessing development
and ADHD in children that were diagnosed with polycythemia.
Infant levels of MgSO4 as well as neonatal outcomes will be retrieved
from computerized charts. 9Acute and Rrcurrent Pericarditis treatment and
Prevention Pathology
Dr. Yoav YinonDr. Michael GurevichDr. Vered IzenbergProf. Ziv Ben-
AriProf. Miri BlankDr. Bruria ShalmonProf. Daniel Stein
Dr. Eran AlonDr. Sagi HarNof Dr. Orly GoiteinProf. David Tanne
Dr. Rina Falb
Dr. Iris MoragProf. Yehuda AdlerDr. Nomy Levin Iaina
Nephrology-Otolaryngology - Head and Neck
NeonatologyDr. Roberto
Spiegelmann'
[email protected]Radio Surgery1Preventive Cardiology and Cardiac
Rehabilitation
Liver Diseases ▓7
ú7ÖK8A29(¦:Ë<>MCC
¤F┼!JÏJ╬
L¿L×sMi!NLQB4R*¾RÚ¾X┼┤YåIZ$[÷ccrûûBÕøøîî
T8═╔
$Ma§lÑn
d³®±ÊMbP?_*+éÇ%,ü┴âä&Þ?'Þ?(?)?MÛ\\sbxppr01\PRTAR9644▄
C´Ç Ü
4dXXA4 DINU"ð
:í▄£ðSMTJ└HP LaserJet
4InputBinOption1RESDLLUniresDLLOrientationPORTRAITResolutionOption1Pa
perSizeLETTERPrintQualityOption1HalftoneHT_PATSIZE_AUTOí" GXXÓ?Ó?
£&£U}
█}
█
}
█%}
I=J}
█
$´@@@¦@╠@╠@▒@┐@ú@ └@
╠@
e@
t@
▒@
ô@ô@Û@@á@9@9@Ú@G@á@9@9@9@£ @@F@-³@┐@²
H²
H
²
H²
I²
H²
M²
A
²
D²
K.²
M
²
V²
A²
E²
G²
C ²
V5²
Z6²
P7²
[8²
C9²
V=²
Z:²
P;²
\<²
C>²
]4²
A'²
@(²
]?²
CH²
VK²
ZI²
bJ²
T@²
CL²
VO²
cM²
bN²
^Q²
CP²
VT²
ZR²
PS²
_A²
CU²
VX²
ZV²
PW²
VB²
CY²
V\²
ZZ²
d[²
`C²
C]²
Va²
R_²
e^²
aD²
C`²
Vd²
fb²
Pc²
aE²
Ce²
VƲ
Rk²
Pf²
MF²
Cæ²
Vô²
Rl²
Pg²
TG²
CH²
Vö²
Rm²
Ph²
Bp²
A²
Vò²
Zn²
di²
kq²
C¿²
Vû²
Ro²
gj²
lr²
M
²
Vñ~
ZZúC²
hѲ
ks²
Cª²
Vù²
R~²
et²
kç²
Cæ²
Vá²
o²
Pu²
kê²
Cí²
Vÿ²
oDz
Pv²
kë²
CL²
VÖ²
nü²
iw²
qè²
Ró²
Vܲ
n²
ix²
Tï²
U²
Vø²
jé²
iy²
Tî²
Ce²
V£²
jâ²
iz²
rì²
R-²
Vز
jä²
i{²
TIJ
tH²
Vײ
jà²
i|²
BŲ
Rú²
Vƒ²
på²
m}²
Aɲ
Tº²
B²
B²
D²
L#²
A²
-X+²
-Y,²
-O*²
-s3²
-N-²
B²
A²
D
²
B/²
BÎD@
lFFFFFFFFFFFFFFFFFFFFFFFFFFFFFFF @!@"Ë
@#ó@²
A²
A²
E²
A0²
F²
!T-²
!R!²
!P²
!Q²
!T2²
"R ²
"R²
"S"²
"T1²
"U²
#A%²
#A&²
#E$²
#W)²
#A
Î
h<FFF>Â
@<dïï´7©Ü""ð╔Ûy¨║╬îé¬K®
Ó╔Ûy¨║╬îé¬K®
fmailto:[email protected]ü¶;H»,é]─à'cѽ©î
ð╔Ûy¨║╬îé¬K®
Ó╔Ûy¨║╬îé¬K®
Xmailto:[email protected];yXü¶;H»,é]─à'cѽ©Þ
ð╔Ûy¨║╬îé¬K®
#[email protected]
Ó╔Ûy¨║╬îé¬K®
jmailto:[email protected]ü¶;H»,é]─à'cѽ©▄
ð╔Ûy¨║╬îé¬K®
[email protected]
Ó╔Ûy¨║╬îé¬K®
dmailto:[email protected]ü¶;H»,é]─à'cѽ©Ìð╔Ûy¨║╬îé¬K®
[email protected]Ó╔Ûy¨║╬îé¬K®
fmailto:[email protected]ü¶;H»,é]─à'cѽ©┌ð╔Ûy¨║╬îé¬K®
[email protected]Ó╔Ûy¨║╬îé¬K®
dmailto:[email protected]ü¶;H»,é]─à'cѽ©┬ð╔Ûy¨║╬îé¬K®
[email protected]Ó╔Ûy¨║╬îé¬K®
Xmailto:[email protected]ü¶;H»,é]─à'cѽ©¼ð╔Ûy¨║╬îé¬K®
[email protected]
Ó╔Ûy¨║╬îé¬K®
Lmailto:[email protected]ü¶;H»,é]─à'cѽ©éð╔Ûy¨║╬îé¬K®
Ó╔Ûy¨║╬îé¬K®
Nmailto:[email protected]ü¶;H»,é]─à'cѽRblocked::mailto:eranealon@ya
hoo.com©Óð╔Ûy¨║╬îé¬K®
[email protected] Ó╔Ûy¨║╬îé¬K®
fmailto:[email protected]ü¶;H»,é]─à'cѽgg D
T8═╔
x
d³®±ÊMbP?_*+éÇ% ü┴âä&Þ?'Þ?(?)?í" Ó?Ó?!£&£U
>Â@ïï´7gg D
T8═╔
¡y
d³®±ÊMbP?_*+éÇ% ü┴âä&Þ?'Þ?(?)?í" Ó?Ó?£&£U
>Â@ïï´7gg D
■ Óàƒ‗¨Oh½æ+'│┘0╝HP`x
É
£
¿┤þ-sheba-Hilla my love-Microsoft
Excel@ÇÕ¶^0╬@Çr¤-)Ù╠@Ç╗®ACÐ■ ı═ı£.ôù+,¨«Dı═ı£.ôù+,¨«╠HP
X`hp
x
ñþ
-ÔÚýÚÕ´1ÔÚýÚÕ´2ÔÚýÚÕ´3
-
ÔýÚÕÕ· ‗ßÕÒõ 8@
_PID_HLINKSþAÈ<J8 'mailto:[email protected]
mailto:[email protected]:[email protected]\
mailto:[email protected],-
&mailto:[email protected]'mailto:Ziv.Ben-
[email protected]/&mailto:[email protected]
)mailto:[email protected]
mailto:[email protected];J8-
'mailto:[email protected]
- !"#$%&'()*+,-./0123456789:;<=■ ?
@ABCDE■ GHIJKLM■ ² ■
Root Entry
└F■ Workbook +zSummaryInformation( >DocumentSummaryIn
formation8 F